Genkyotex Plans 'Solo' Pivotal Trials After Lead Product Hits Phase II PBC Targets

Cirrhosis
Primary biliary cholangitis causes the immune system to attack bile ducts • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip